LEADER 02384oas 22010453 450 001 9910141389903321 005 20260218110914.0 011 $a2045-0915 035 $a(OCoLC)859263962 035 $a(CONSER) 2012243738 035 $a(CKB)2670000000263870 035 $a(DE-599)ZDB2692808-5 035 $a(MiAaPQ)3748001 035 $a(DE-599)2692808-5 035 $a(EXLCZ)992670000000263870 100 $a20131002a20129999 uy a 101 0 $aeng 135 $aur||||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aCNS oncology 210 1$a[London] :$cFuture Medicine,$d[2012]- 210 31$a[Milton Park, Oxfordshire] :$cTaylor & Francis Group 210 4$dİ2012- 215 $a1 online resource 300 $aRefereed/Peer-reviewed 311 08$a2045-0907 517 1 $aCentral nervous system oncology 517 1 $aCNS Oncol 531 0 $aCNS oncol. 606 $aCentral nervous system$xTumors$vPeriodicals 606 $aNervous System Neoplasms 606 $aCentral nervous system$xTumors$2fast 608 $aPeriodical. 608 $aPeriodicals$2fast 615 0$aCentral nervous system$xTumors 615 12$aNervous System Neoplasms. 615 7$aCentral nervous system$xTumors 676 $a616.99481 801 0$bVZR 801 1$bVZR 801 2$bVZR 801 2$bOCLCF 801 2$bCUI 801 2$bOCLCQ 801 2$bCOO 801 2$bOCLCA 801 2$bTXA 801 2$bUX1 801 2$bOCLCO 801 2$bNLE 801 2$bOCLCQ 801 2$bVT2 801 2$bOCLCQ 801 2$bUKMGB 801 2$bWYU 801 2$bOCLCO 801 2$bOCLCA 801 2$bUKBTH 801 2$bUHL 801 2$bLIP 801 2$bOCLCQ 801 2$bSFB 801 2$bUKSSU 801 2$bUK7LJ 801 2$bLDP 801 2$bVLY 801 2$bHS0 801 2$bEQF 801 2$bUWK 801 2$bLUN 801 2$bSXB 801 2$bLHT 801 2$bOCLCQ 801 2$bRDF 801 2$bOCLCQ 801 2$bOCLCO 801 2$bOCLCQ 801 2$bOCLCO 801 2$bOCLCQ 801 2$bNLM 801 2$bUEJ 801 2$bDLC 801 2$bOCLCL 801 2$bU3W 906 $aJOURNAL 912 $a9910141389903321 996 $aCNS oncology$92023960 997 $aUNINA